Back to News
Market Impact: 0.25

Validea Detailed Fundamental Analysis

MDTNDAQ
Company FundamentalsAnalyst InsightsDerivatives & VolatilityCapital Returns (Dividends / Buybacks)Market Technicals & FlowsHealthcare & BiotechInvestor Sentiment & Positioning
Validea Detailed Fundamental Analysis

Validea's Multi-Factor Investor model, based on Pim van Vliet's low-volatility strategy, rated Medtronic PLC (MDT) at 75%, falling below the 80% threshold for 'some interest'. Despite passing market capitalization and standard deviation criteria, the large-cap medical equipment stock received 'NEUTRAL' scores for momentum and net payout yield, culminating in a 'FAIL' on its final rank within the strategy's framework.

Analysis

According to a Validea fundamental report, Medtronic PLC (MDT) does not meet the full criteria of the Multi-Factor Investor model, which is based on Pim van Vliet's low-risk, high-return strategy. The company received an overall rating of 75%, falling below the 80% threshold that indicates strategic interest and culminating in a 'FAIL' on its final rank. While MDT, a large-cap medical equipment stock, successfully passed the model's screens for market capitalization and low standard deviation, it faltered on key return-driving factors. Specifically, it received 'NEUTRAL' scores for both 'Twelve Minus One Momentum' and 'Net Payout Yield', indicating a lack of strong recent price performance and a modest return of capital to shareholders. This mixed result suggests that while MDT exhibits the desired low-volatility characteristics, it currently lacks the momentum and yield attributes that the model seeks in combination to identify outperforming conservative stocks.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment